Beyond Borders: Global biotechnology report 2010
Beyond Borders: Global biotechnology report 2010
Beyond Borders: Global biotechnology report 2010
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
71 European yearly biotech financings, 1999–2009<br />
71 Canadian yearly <strong>biotechnology</strong> financings, 2000–09<br />
72 Capital raised by Canadian province, 2009<br />
72 Capital raised by leading Canadian biotech clusters, 2009<br />
73 Australian biotech public equity raised, 2002–09<br />
76 Selected 2009 M&As<br />
77 Selected 2009 alliances<br />
82 US M&As, 1999–2009<br />
82 US strategic alliances remain strong<br />
83 European M&As, 2005–09<br />
83 European alliances held steady in 2009<br />
87 Selected approvals by US companies, 2009<br />
88 FDA product approvals, 1996–2009<br />
89 European clinical pipeline by country, 2009<br />
90 European Phase III pipeline by indication, 2009<br />
91 Selected product approvals by European companies, 2009<br />
93 Selected outcomes-based pricing agreements<br />
94 FDA orphan drug approvals and designations, 1990-2009<br />
96 State of personalized medicine adoption<br />
105
Change language